RNA-LNP Therapeutics Panel Discussion

2022 WMIF | RNA Therapeutics | Lessons LearnedПодробнее

Q&A on LNP Cell-Specific DeliveryПодробнее

RNA Therapeutics - Full TalkПодробнее

Clinical and Commercial Manufacturing of mRNA Therapeutics: Opportunities and ChallengesПодробнее

2022 Mitochondrial Medicine Next Gen Therapeutics Panel DiscussionПодробнее

Polysarcosine-Functionalized Lipid Nanoparticles for Therapeutic mRNA DeliveryПодробнее

RNA-based Drugs Including Delivery of Antibodies and Vaccines Using mRNAПодробнее

New Approaches for LNP Design and Microfluidic Manufacturing for Vaccines and CAR T Cell TherapyПодробнее

RNA Therapeutics - DiscussionПодробнее

Process & Analytical Insights for GMP Manufacturing of mRNA-Lipid NanoparticlesПодробнее

Cationic lipids offer new possibilities in liposome and LNP engineering for RNA therapeuticsПодробнее

Translating mRNA-Based Medicines from Concept to ClinicПодробнее

RNA Therapeutics: Going Beyond the LiverПодробнее

How RNA Therapeutics will Change Cardiovascular Medicine (John P. Cooke, MD) December 21, 2020Подробнее

Achieving mRNA-LNP Delivery Beyond the LiverПодробнее

Optimizing RNA Therapeutics - Virtual EventПодробнее

Science & serendipity: lipid nanoparticles that enable COVID-19 mRNA vaccines - Gairdner LecturesПодробнее

Development of mRNA and its ApplicationsПодробнее

mRNA Basics Analytical Testing for mRNA TherapeuticsПодробнее